MarketAbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?Yahoo2026.06.22Source: YahooThe company is already renowned by many as a giant in the segment.← Back to News